14 CPD Points
Day 1 – Wednesday 26th July 2017
Theme of the Day: Challenging Breast Lesions
|08.30||ER/IOE||Registration and coffee|
|09.00||ALH||Immunohistochemistry in breast pathology: when does it help? Applications and challenges|
|09.45||CQ||Challenging breast lesions: Spindle cell lesions|
|11.00||CQ, ALH, JT, IOE, ER||Slide seminar1: view of the cases and Case discussion|
|12.00||SEP||Proliferative breast lesions: Spectrum, diagnostic features and DD|
|13.30||ER||Challenging breast lesions: Papillary lesions|
|14.15||JT||Challenging breast lesions: Fibroepithelial lesions|
|14.45||CQ, JT, SEP, ALH||Slide seminar2: view of the cases and Case discussion|
|15.45||CQ||Challenging breast lesions: Uncommon but tricky breast lesions|
|16.20||IOE||Breast pathology EQA: Performance issues and digital application|
|17.00||IOE, SEP, CQ, JT, ER||Meet the experts and discussion|
|20.00||Course Dinner: University campus|
Day 2 – Thursday 27th July 2017
Theme of the Day: Keys Issues of Clinical Relevance in Breast Pathology
|08.30||Registration and Coffee|
|09.00||SEP, AS, CQ, ER||Session 1 Keys Issues of Clinical Relevance in Breast Pathology*|
|11.00||SEP, AS, CQ, IOE, JT, ER||Slide seminar3: view of the cases and Case discussion|
|13.20||SEP, AS, UK, IOE||Session 2 Keys Issues of Clinical Relevance in Breast Pathology***|
|14.45||SEP, AS, CQ, IOE, ER||Slide seminar 4: view of the cases and Case discussion|
|15.50||IOE||An update on the molecular pathology of breast cancer|
Slide seminars: 5 hours in two days: Discussion of cases circulated as online material with likely differentials. Discussion of interesting cases with expert approach to diagnosis using microscope and a projection screen.
SEP -Breast specimens handling: Guidelines and approaches (20 minutes).
UK-What is important in handling post neoadjuvant therapy treated cases (specimen examination and reporting). What is the importance between complete pathological response and minimal residual disease in the breast, (ie do we need IHC? Does it make a difference? Which system should we use in routine practice)? (20 minutes)
CQ-Update on the staging of breast cancer (using TNM8, NPI…), staging multifocal, bilateral cancers and recurrent cancers, node positivity after neoadjuvant therapy (20 minutes).
AS– PLCIS, mass forming LCIS and LCIS with necrosis; diagnostic and management issues (20 minutes).
General discussion (10 minutes).
AS-Diagnostic challenges in breast Pathology (soft tissue lesions, vascular lesions, skin adnexal lesions and rare mammary lesions (20 minutes).
SEP-Dealing vacuum biopsy and vacuum excision of breast lesions (best practice Vs work load), also dealing with subsequent surgical specimen if no residual lesions present and dealing with the second line VAB regarding upgrade of atypia and reporting. B1 Vs B2 and use of B4 and B5c, An update on the management of B3 lesions (20 minutes).
UK-An update on tumour heterogeneity and tumour infiltrating lymphocytes (TILs) and dealing with sentinel nodes: what reporting pathologists need to know? (20 minutes).
IOE-Using Oncotype DX in the UK: An update (10 minutes).
Kita Williams: Labelling, Tracking & Archiving to Optimise Workflow & Patient Safety (10 minutes)
General discussion (10 minutes).